HER2DX Genomic Assay in HER2-positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from PHERGain Phase II Trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Clinical Cancer Research

Topics

Medicine

Cancer Oncology

Internal Medicine

Gastroenterology

Radiology, Nuclear Medicine And Imaging

Show all topics

DOI

10.1158/1078-0432.ccr-24-0464

License

CC-BY-NC-ND